Market Overview

Lightning Round: Jim Cramer Advises His Viewers On Gilead, Exxon Mobil And More

Related GILD
Why Gilead, Galapagos Shares Are Trading Higher
Fast Money Picks For September 12
Express Scripts taking credit for Gilead's planned launch of generic HCV meds (Seeking Alpha)
Related HALO
The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel
50 Biggest Movers From Friday

On CNBC's "Mad Money Lightning Round", Jim Cramer said Gilead Sciences, Inc. (NASDAQ: GILD) is too cheap to sell at $73, but it's not his favorite stock. He thinks there is a $5 downside risk.

Cramer likes Halozyme Therapeutics, Inc. (NASDAQ: HALO) and he would own it. He added that the company has fabulous technology.

Exxon Mobil Corporation (NYSE: XOM) is fine, said Cramer and he added that he prefers Chevron Corporation (NYSE: CVX).

Skechers USA Inc (NYSE: SKX) reported numbers that were superior to the other companies in the sector, said Cramer.

AMC Entertainment Holdings Inc (NYSE: AMC) isn't going higher and Cramer would stay away.

Glacier Bancorp, Inc. (NASDAQ: GBCI) trades at a very big premium to a book value, but if the Fed raises rates, the stock is going higher, said Cramer. He added it's more expensive than the other banks.

Cramer likes Timkensteel Corp (NYSE: TMST) but he can't recommend it as a buy.

Posted-In: CNBC mad money Lightning Round Jim CramerMedia


Related Articles (CVX + AMC)

View Comments and Join the Discussion!

Here's What's Coming Up On PreMarket Prep For November 9

Citigroup, Nordstrom, Qorvo: Fast Money Picks For November 9